England Edges Toward Hepatitis C Elimination With 100,000+ Treated

England is moving toward a milestone that seemed distant just a decade ago: the near-total elimination of hepatitis C. More than 100,000 people have now been treated through the National Health Service, a figure that represents not just a number but a fundamental shift in how the country approaches a disease that once seemed intractable.

The path to this achievement rests on two strategic pillars. The first is opt-out testing—a deceptively simple idea with profound consequences. Rather than waiting for patients to request a hepatitis C test, the NHS now screens people as a default part of routine care, with the option to decline. This inverts the traditional model of disease detection. Instead of relying on people to know they might be infected and seek help, the system finds them. The second pillar is precision screening combined with localized care. By targeting testing toward populations at higher risk and delivering treatment close to where people live—in community clinics, primary care settings, and local hospitals rather than only in specialized centers—the NHS has removed friction from the treatment pathway.

These strategies have compounded. Each person treated reduces transmission. Each person cured becomes a success story that builds trust in communities where hepatitis C has long been stigmatized. The disease, which can cause liver damage and cirrhosis if left untreated, has been associated with intravenous drug use, a fact that has historically made patients reluctant to seek care and healthcare systems reluctant to prioritize screening. England's approach sidesteps that dynamic by making testing routine and treatment accessible.

The scale of what has been accomplished is worth sitting with. One hundred thousand people is not an abstract number. It represents 100,000 individuals who were living with a chronic viral infection, many of them unaware they carried it. Some had already developed liver damage. Others would have, had treatment been delayed further. Now they are cured. Hepatitis C is one of the few viral infections that modern medicine can eliminate entirely from a person's body—cure rates exceed 95 percent with current antiviral drugs—and England has deployed that capability at a population level.

The implications extend beyond England's borders. The country is positioning itself as one of the first nations globally to approach hepatitis C elimination rather than mere management. The World Health Organization has set elimination targets for member states, but few have moved as decisively. England's model—combining universal screening with accessible treatment and local delivery—offers a template. It demonstrates that elimination is not a distant aspiration but an achievable goal within a decade or so, provided the political will and funding exist.

What remains is the final stretch. Reaching elimination means not just treating the majority of infected people but finding and treating the hardest-to-reach populations: people experiencing homelessness, those in the criminal justice system, undocumented migrants, and others on the margins of healthcare access. These groups often carry disproportionate disease burden. The opt-out testing strategy helps, but it requires sustained effort and cultural change within institutions that have historically struggled to serve these populations well. England's next phase will test whether the momentum built over the past few years can carry through to the finish line.